WO2003049672A3 - Methods and compositions for treating flavivirus-mediated disease - Google Patents

Methods and compositions for treating flavivirus-mediated disease Download PDF

Info

Publication number
WO2003049672A3
WO2003049672A3 PCT/US2002/034659 US0234659W WO03049672A3 WO 2003049672 A3 WO2003049672 A3 WO 2003049672A3 US 0234659 W US0234659 W US 0234659W WO 03049672 A3 WO03049672 A3 WO 03049672A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
mediated disease
treating flavivirus
flavivirus
Prior art date
Application number
PCT/US2002/034659
Other languages
French (fr)
Other versions
WO2003049672A2 (en
Inventor
Kazuo Takahashi
Shiro Shigeta
Kirk A Field
Original Assignee
Microbiotix Inc
Kazuo Takahashi
Shiro Shigeta
Kirk A Field
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiotix Inc, Kazuo Takahashi, Shiro Shigeta, Kirk A Field filed Critical Microbiotix Inc
Priority to AU2002342188A priority Critical patent/AU2002342188A1/en
Publication of WO2003049672A2 publication Critical patent/WO2003049672A2/en
Publication of WO2003049672A3 publication Critical patent/WO2003049672A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Compositions and methods comprising a sulfated sialyl lipid compound are described for treating a flavivirus-mediated disease, such as dengue fever or hepatitis C, in an individual.
PCT/US2002/034659 2001-10-30 2002-10-29 Methods and compositions for treating flavivirus-mediated disease WO2003049672A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002342188A AU2002342188A1 (en) 2001-10-30 2002-10-29 Methods and compositions for treating flavivirus-mediated disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34073501P 2001-10-30 2001-10-30
US60/340,735 2001-10-30

Publications (2)

Publication Number Publication Date
WO2003049672A2 WO2003049672A2 (en) 2003-06-19
WO2003049672A3 true WO2003049672A3 (en) 2003-07-17

Family

ID=23334710

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/034659 WO2003049672A2 (en) 2001-10-30 2002-10-29 Methods and compositions for treating flavivirus-mediated disease

Country Status (2)

Country Link
AU (1) AU2002342188A1 (en)
WO (1) WO2003049672A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008074720A (en) * 2006-09-19 2008-04-03 Noguchi Inst Gm3 sugar chain probe
EP2349257B1 (en) 2008-06-17 2013-11-27 Universidade Federal de Minas Gerais-UFMG Use of paf receptor for treating infections caused by flaviviridae
WO2023062386A1 (en) * 2021-10-14 2023-04-20 Owlstone Medical Limited Method for the synthesis of evoc probes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957107A1 (en) * 1996-05-16 1999-11-17 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity
WO2000038697A1 (en) * 1998-12-29 2000-07-06 Glukor, Inc. Treatment and prevention of hiv and other viral infections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957107A1 (en) * 1996-05-16 1999-11-17 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity
WO2000038697A1 (en) * 1998-12-29 2000-07-06 Glukor, Inc. Treatment and prevention of hiv and other viral infections

Also Published As

Publication number Publication date
WO2003049672A2 (en) 2003-06-19
AU2002342188A8 (en) 2003-06-23
AU2002342188A1 (en) 2003-06-23

Similar Documents

Publication Publication Date Title
MXPA03008884A (en) Low glycemic response compositions.
PL369567A1 (en) 1,6-naphthyridine derivatives as antidiabetics
AU2002303583A1 (en) Air freshening compositions, articles comprising same and methods for preparing same
HK1047584A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process.
WO2002102586A3 (en) Cellulose-polymer composites and methods for manufacturing same
WO2005037470A3 (en) Encapsulated nanoparticles, products containing the same, and methods for using the same
HUP0402385A3 (en) 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof
EP1470240A4 (en) Methods and compositions for treating cardiovascular disease using 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 21656, 32427, 2402, 7747,1720, 9151, 60491, 1371, 7077, 33207, 1419, 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165,2
DE60210598D1 (en) 3,7-DIAZABICYCLOc3.3.1Ü FORMULATIONS AS ANTIARRHYTHMIKA
AP2004003045A0 (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same.
AU4996100A (en) (s,r) formoterol methods and compositions
AU2003246862A8 (en) Assembly for hydrosylilation, method for preparing same and silicone compositions incorporating same
NO20022969L (en) Compositions and Methods for L-Nucleosides, L-Nucleotides and Analogs thereof
AP2006003530A0 (en) Immunogenic HIV compositions and related methods.
AU2001238131A1 (en) Polymer compositions useful as dye complexing agents, and processes for preparing same
HK1060129A1 (en) Novel piperidinecarboxamide derivatives, method f or preparing same and pharmaceutical compositions containing same.
WO2003049672A3 (en) Methods and compositions for treating flavivirus-mediated disease
DE50001659D1 (en) HARD CARAMELS WITH IMPROVED STORAGE STABILITY
AU2001274422A1 (en) Compositions based on aminoacids, suitable for improving muscle performance
IL163712A0 (en) 1,2-Dihydropyrazol-3-ones as cytokine mediators
PT1408035E (en) METHOD FOR THE PREPARATION OF DERIVATIVES OF 1,5-DIARIL-3-TRIFLUOROMETHYL-DELTA2-PYRAZOLINS THAT ARE RACERICALLY AND ENHANCERLY PURE
WO2003041639A3 (en) Methods and compositions for treating rotavirus-mediated disease
AU2002305019A1 (en) Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels
AU2002353766A1 (en) Low humidity uptake solid pyrotechnic compositions, and methods for making the same
ITRM20010029V0 (en) IMPROVED ARMCHAIR, IN PARTICULAR FOR AIRCRAFT.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP